Economic evaluation of pharmaceuticals

Research output: Chapter in Book/Report/Conference proceedingEncyclopaedia / Dictionary EntryOtherpeer-review

Abstract

Around the world, health policy decision makers and payers are compelled to ensure delivery of quality health care under ever-tighter budgetary constraints and increasing demand. This is due to many factors, including ageing populations, expensive health technologies, and financial uncertainty. Yet, despite all the heterogeneity across different drug markets, a constant fact is that costs and cost-effectiveness are crucial determinants of the feasibility and affordability of pharmacotherapy. This chapter will provide an overview of the different approaches to economic evaluation of pharmacotherapies and describe health technology assessment methods used to outline the process in drug reimbursement.

Original languageEnglish
Title of host publicationEncyclopedia of Pharmacy Practice and Clinical Pharmacy
EditorsZaheer-Ud-Din Babar, Zubin Austin, Ahmed Awaisu, Timothy Chen, Louise Curley, Danijela Gnjidic, Arijana Meštrović, Kath Ryan
Place of PublicationAmsterdam, The Netherlands
PublisherElsevier
Pages420-434
Number of pages15
Volume2
Edition1st
ISBN (Electronic)9780128127353
ISBN (Print)9780128127360
DOIs
Publication statusPublished - 2019

Keywords

  • Cost-benefit
  • Cost-effectiveness
  • Cost-utility
  • Costs
  • Economic-evaluations
  • Health care
  • Health technology assessment
  • Incremental cost-effectiveness ratio
  • Pharmacotherapy
  • Quality of life

Cite this

Ademi, Z., & Liew, D. (2019). Economic evaluation of pharmaceuticals. In Z-U-D. Babar, Z. Austin, A. Awaisu, T. Chen, L. Curley, D. Gnjidic, A. Meštrović, & K. Ryan (Eds.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy (1st ed., Vol. 2, pp. 420-434). Elsevier. https://doi.org/10.1016/B978-0-128-12735-3.00034-0